205 related articles for article (PubMed ID: 8847480)
1. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
Haubenwallner S; Essenburg AD; Barnett BC; Pape ME; DeMattos RB; Krause BR; Minton LL; Auerbach BJ; Newton RS; Leff T
J Lipid Res; 1995 Dec; 36(12):2541-51. PubMed ID: 8847480
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
Kłosiewicz-Latoszek L; Szostak WB
Eur J Clin Pharmacol; 1991; 40(1):33-41. PubMed ID: 2060543
[TBL] [Abstract][Full Text] [Related]
3. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
Bisgaier CL; Essenburg AD; Barnett BC; Auerbach BJ; Haubenwallner S; Leff T; White AD; Creger P; Pape ME; Rea TJ; Newton RS
J Lipid Res; 1998 Jan; 39(1):17-30. PubMed ID: 9469582
[TBL] [Abstract][Full Text] [Related]
4. Fibrates and triglyceride metabolism.
Schwandt P
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S41-3. PubMed ID: 2044642
[TBL] [Abstract][Full Text] [Related]
5. Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
Andersson Y; Majd Z; Lefebvre AM; Martin G; Sechkin AV; Kosykh V; Fruchart JC; Najib J; Staels B
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):115-21. PubMed ID: 9888873
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
[TBL] [Abstract][Full Text] [Related]
7. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
Clavey V; Copin C; Mariotte MC; Baugé E; Chinetti G; Fruchart J; Fruchart JC; Dallongeville J; Staels B
Cell Physiol Biochem; 1999; 9(3):139-49. PubMed ID: 10494028
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
Fruchart JC; Duriez P
Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
[TBL] [Abstract][Full Text] [Related]
9. Fibric acids: effects on lipids and lipoprotein metabolism.
Grundy SM; Vega GL
Am J Med; 1987 Nov; 83(5B):9-20. PubMed ID: 3318457
[TBL] [Abstract][Full Text] [Related]
10. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
Krause BR; Barnett BC; Essenburg AD; Kieft KA; Auerbach BJ; Bousley R; Stanfield R; Newton RS; Bisgaier CL
Atherosclerosis; 1996 Nov; 127(1):91-101. PubMed ID: 9006809
[TBL] [Abstract][Full Text] [Related]
12. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.
Chianale J; Vollrath V; Wielandt AM; Amigo L; Rigotti A; Nervi F; Gonzalez S; Andrade L; Pizarro M; Accatino L
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):781-6. PubMed ID: 8615769
[TBL] [Abstract][Full Text] [Related]
13. Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.
Vázquez M; Merlos M; Adzet T; Laguna JC
Br J Pharmacol; 1996 Mar; 117(6):1155-62. PubMed ID: 8882610
[TBL] [Abstract][Full Text] [Related]
14. MDL 29311, a phenolic antioxidant, interferes with the interaction of apoC with VLDL: a possible explanation for its triglyceride-lowering effect.
Sheetz MJ
J Lipid Res; 1995 Dec; 36(12):2609-21. PubMed ID: 8847487
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.
Alegret M; Ferrando R; Vázquez M; Adzet T; Merlos M; Laguna JC
Br J Pharmacol; 1994 Jun; 112(2):551-6. PubMed ID: 7915611
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates.
Lefebvre AM; Peinado-Onsurbe J; Leitersdorf I; Briggs MR; Paterniti JR; Fruchart JC; Fievet C; Auwerx J; Staels B
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1756-64. PubMed ID: 9327774
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.
Chan DC; Watts GF; Ooi EM; Ji J; Johnson AG; Barrett PH
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1831-7. PubMed ID: 18566295
[TBL] [Abstract][Full Text] [Related]
18. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
Roglans N; Bellido A; Rodríguez C; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC
Clin Pharmacol Ther; 2002 Dec; 72(6):692-701. PubMed ID: 12496750
[TBL] [Abstract][Full Text] [Related]
19. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).
Farnier M; Salko T; Isaacsohn JL; Troendle AJ; Dejager S; Gonasun L
Am J Cardiol; 2003 Oct; 92(7):794-7. PubMed ID: 14516878
[TBL] [Abstract][Full Text] [Related]
20. No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased.
Neele DM; Kaptein A; Huisman H; de Wit EC; Princen HM
Biochem Biophys Res Commun; 1998 Mar; 244(2):374-8. PubMed ID: 9514936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
